← Back to headlines
Nkarta shares rise after FDA agreement on amended trial protocol
Nkarta's stock experienced a rise following an agreement with the FDA regarding an amended trial protocol, indicating progress in its clinical development.
16 Apr, 17:38 — 16 Apr, 17:38
Sources
Showing 1 of 1 sources
